I. V. Chebotar

429 total citations
59 papers, 249 citations indexed

About

I. V. Chebotar is a scholar working on Molecular Biology, Molecular Medicine and Endocrinology. According to data from OpenAlex, I. V. Chebotar has authored 59 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Molecular Medicine and 17 papers in Endocrinology. Recurrent topics in I. V. Chebotar's work include Antibiotic Resistance in Bacteria (24 papers), Bacterial biofilms and quorum sensing (19 papers) and Bacterial Identification and Susceptibility Testing (10 papers). I. V. Chebotar is often cited by papers focused on Antibiotic Resistance in Bacteria (24 papers), Bacterial biofilms and quorum sensing (19 papers) and Bacterial Identification and Susceptibility Testing (10 papers). I. V. Chebotar collaborates with scholars based in Russia, United States and United Kingdom. I. V. Chebotar's co-authors include Anna Lazareva, Nikolay Mayanskiy, Vladimir Mikhailovich, Dmitry A. Shagin, И А Новиков, I. V. Podoprigora, Peter V. Evseev, А. Г. Погорелов, Dmitriy Korostin and Andrey Shelenkov and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Frontiers in Microbiology.

In The Last Decade

I. V. Chebotar

48 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. V. Chebotar Russia 9 105 104 65 28 27 59 249
Cary L. Honnold United States 9 113 1.1× 130 1.3× 74 1.1× 16 0.6× 16 0.6× 13 352
Yanping Xu China 9 58 0.6× 138 1.3× 54 0.8× 39 1.4× 23 0.9× 22 268
Irene Merino Spain 7 84 0.8× 107 1.0× 78 1.2× 21 0.8× 12 0.4× 11 220
Anina Ratjen United States 7 175 1.7× 96 0.9× 47 0.7× 33 1.2× 12 0.4× 7 320
Chi-Ho Lin Hong Kong 5 66 0.6× 180 1.7× 105 1.6× 24 0.9× 52 1.9× 5 251
Kaelyn C. Cummins United States 4 83 0.8× 154 1.5× 66 1.0× 35 1.3× 11 0.4× 10 253
Christopher Connor United Kingdom 8 107 1.0× 191 1.8× 119 1.8× 38 1.4× 50 1.9× 15 384
Suzhen Ma China 7 113 1.1× 130 1.3× 56 0.9× 31 1.1× 60 2.2× 11 290
Maura Benson United States 3 71 0.7× 154 1.5× 66 1.0× 35 1.3× 11 0.4× 4 291
Adam Griffith United States 10 125 1.2× 90 0.9× 122 1.9× 19 0.7× 14 0.5× 11 396

Countries citing papers authored by I. V. Chebotar

Since Specialization
Citations

This map shows the geographic impact of I. V. Chebotar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. V. Chebotar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. V. Chebotar more than expected).

Fields of papers citing papers by I. V. Chebotar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. V. Chebotar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. V. Chebotar. The network helps show where I. V. Chebotar may publish in the future.

Co-authorship network of co-authors of I. V. Chebotar

This figure shows the co-authorship network connecting the top 25 collaborators of I. V. Chebotar. A scholar is included among the top collaborators of I. V. Chebotar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. V. Chebotar. I. V. Chebotar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chebotar, I. V., et al.. (2025). Experimental evolution of cefiderocol resistance in Pseudomonas aeruginosa. Heliyon. 11(13). e43681–e43681.
2.
Chebotar, I. V., et al.. (2025). Detection of virulence factors in opportunistic bacteria: advances, challenges, and practical implementation. Frontiers in Microbiology. 16. 1638925–1638925.
3.
Mikhailovich, Vladimir, et al.. (2024). Stenotrophomonas maltophilia virulence: a current view. Frontiers in Microbiology. 15. 1385631–1385631. 5 indexed citations
4.
Chebotar, I. V., et al.. (2023). New mutations in genes associated with cefiderocol resistance in a clinical isolate of Pseudomonas aeruginosa. SHILAP Revista de lepidopterología. 25(4). 401–407.
5.
6.
Kasimova, Anastasiya A., Mikhail M. Shneider, Peter V. Evseev, et al.. (2023). The structure of Klebsiella pneumoniae K108 capsular polysaccharide is similar to Escherichia coli colanic acid. International Journal of Biological Macromolecules. 244. 125403–125403. 2 indexed citations
7.
Chebotar, I. V., et al.. (2023). Clonal diversity, antimicrobial resistance, and genome features among nonfermenting gram-negative bacteria isolated from patients with cystic fibrosis in Russia. Diagnostic Microbiology and Infectious Disease. 108(2). 116102–116102. 3 indexed citations
8.
Chaplin, Andrei V., et al.. (2022). Characteristics of Stenotrophomonas maltophilia isolates from cystic fibrosis patients in Russia. Russian Clinical Laboratory Diagnostics. 67(5). 315–320. 4 indexed citations
10.
Kuleshov, Konstantin V., Yulia Mikhaylova, Gabriele Margos, et al.. (2021). Mobile Colistin Resistance Genetic Determinants of Non-Typhoid Salmonella enterica Isolates from Russia. Microorganisms. 9(12). 2515–2515. 6 indexed citations
11.
Новиков, И А, Natalia Gogoleva, I. V. Chebotar, et al.. (2021). Life-On-Hold: Lanthanoids Rapidly Induce a Reversible Ametabolic State in Mammalian Cells. Biology. 10(7). 607–607. 1 indexed citations
12.
Chaplin, Andrei V., et al.. (2021). Genome features and antibiotic resistance of Pseudomonas aeruginosa strains isolated in patients with cystic fibrosis in the Russian Federation. Russian Clinical Laboratory Diagnostics. 66(10). 629–634. 3 indexed citations
13.
Chebotar, I. V., et al.. (2021). The classification of bacterial survival strategies in the presence of antimicrobials. Microbial Pathogenesis. 155. 104901–104901. 18 indexed citations
14.
Lazareva, Anna, et al.. (2019). INTEGRON DIVERSITY IN BLAVIM-2-CARRYING CARBAPENEM-RESISTANT CLINICAL PSEUDOMONAS AERUGINOSA ISOLATES. Russian Clinical Laboratory Diagnostics. 64(8). 497–502. 1 indexed citations
15.
Shagin, Dmitry A., et al.. (2019). Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate. Journal of Global Antimicrobial Resistance. 17. 309–311. 10 indexed citations
16.
Новиков, И А, et al.. (2019). A rapid method of whole cell sample preparation for scanning electron microscopy using neodymium chloride. Micron. 124. 102687–102687. 9 indexed citations
17.
Chebotar, I. V., et al.. (2014). Strategy of control for bacterial biofilm processes. Journal Infectology. 1 indexed citations
18.
Chebotar, I. V., et al.. (2014). Acinetobacter: Microbiological, Pathogenetic and Resistant Properties. Annals of the Russian academy of medical sciences. 69(9-10). 39–50. 27 indexed citations
19.
Погорелов, А. Г., et al.. (2014). Scanning Electron Microscopy of Biofilms Adherent to the Inner Catheter Surface. Bulletin of Experimental Biology and Medicine. 157(5). 711–714. 6 indexed citations
20.
Chebotar, I. V., et al.. (2012). Pseudomonas aeruginosa: характеристика биопленочного процесса. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026